Evaluation of adverse events in cats receiving long-term piroxicam therapy for various neoplasms

Journal of Feline Medicine and Surgery

Volumn 12, Issue 4, 2010, Pages 262-268

  Bulman Fleming, Julie C ^a   Turner, T R ^a   Rosenberg, Mona P ^a  

^a Veterinary Cancer Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG SCREENING; FEMALE; MALE; NEOPLASM; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VOMITING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAT DISEASES; CATS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; MALE; NEOPLASMS; PIROXICAM; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VOMITING;

EID: 77950281553     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.09.007     Document Type: Article

References (18)

1. Budberg, Jones 2000.
2. Carroll G.L., and Simonson S.M. Recent developments in non-steroidal anti-inflammatory drugs in cats. J Am Anim Hosp Assoc 41 (2005) 347-354
3. Lascelles B.D.X., Court M.H., Hardie E.M., and Robertson S.A. Non-steroidal anti-inflammatory drugs in cats: a review. Vet Anaesth Analg 34 (2007) 228-250
4. Beam S.L., Rassnick K.M., Moore A.S., and McDonough S.P. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Vet Pathol 40 (2003) 496-500
5. Raz A. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer. Biochem Pharmacol 63 (2002) 343-347
6. Heller D.A., Fan T.M., deLorimer L.P., et al. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. J Vet Intern Med 21 (2007) 1948-1955
7. Knapp D.W., Richardson R.C., Chan T.C., et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8 (1994) 273-278
8. Schmidt B.R., Glickman N.W., DeNicola D.B., deGortari A.E., and Knapp D.W. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 218 (2001) 1783-1786
9. Mohammed S.I., Craig B.A., Mutsaers A.J., et al. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther 2 (2003) 183-188
10. Heeb H.L., Chun R., Koch D.E., Goatly M.A., and Hunter R.P. Single dose pharmacokinetics of piroxicam in cats. J Vet Pharmacol Ther 26 (2003) 259-263
11. Jones J.J., and Budsberg S.C. Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats. J Am Vet Med Assoc 217 (2000) 721-729
12. Heeb H.L., Chun R., Koch D.E., et al. Multiple dose pharmacokinetics and acute safety of piroxicam. J Vet Pharmacol Ther 28 (2005) 447-452
13. Wilson H.M., Chun R., Larson V.S., Kurzman I.D., and Vail D.M. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases. J Am Vet Med Assoc 231 (2007) 101-106
14. Spugnini E.P., Crispi S., Scarabello A., Caruso G., Citro G., and Baldi A. Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations. J Exp Clin Cancer Res 19 27 (2008) 6
15. Kisseberth W.C., Vail D.M., Yaissle J., et al. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a veterinary cooperative oncology group study. J Vet Intern Med 22 (2008) 83-88
16. Withrow S.J., and Vail D.M. Cancer chemotherapy. Withrow and MacEwan's small animal clinical oncology. 4th edn (2007), Saunders Elsevier, St Louis 163-188
17. Hampshire V.A., Doddy F.M., Post L.O., et al. Adverse drug event reports at the United States Food and Drug Administration Center for Veterinary Medicine. J Am Vet Med Assoc 225 4 (2004) 533-536
18. Marioni-Henry K., Schwarz T., Weisse C., and Muravnick K. Cystic nasal adenocarcinoma in a cat treated with piroxicam and chemoembolization. J Am Anim Hosp Assoc 43 (2007) 347-351